1. PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation. (26th February 2018) Authors: Mao, Yize; Huang, Xin; Shuang, Zeyu; Lin, Guohe; Wang, Jun; Duan, Fangting; Chen, Jianlin; Li, Shengping Journal: Cancer medicine Issue: Volume 7:Number 4(2018:Apr.) Page Start: 1285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗